In a startling reversal of fortunes, UBS heavyweight Sergio Ermotti has tumbled to fifth place in the national earnings rankings. Despite overseeing the most complex banking integration in Swiss history, Ermottiâs compensation remained stagnant at CHF 14.9 million. While a massive sum by any standard, it pales in comparison to the heights reached by pharma and private banking rivals. The contrast is even sharper elsewhere: Flemming Ărnskov of Galderma saw an 8% dip to CHF 17.6 million, and Partners Groupâs David Layton faced a 6% cut. Even the mighty NestlĂ© is seeing a shift; while new CEO Philipp Navratil earned CHF 4.8 million in just four months, the company remains shrouded in silence regarding his predecessor, Laurent Freixe, following a scandalous exit. The message is clear: even at the top, the Swiss corporate machine is beginning to differentiate between steady hands and high-growth superstars.